All News
Filter News
Found 808,898 articles
-
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, July 9, 2021 and Encourages All Shareholders to Vote
6/11/2021
Based on a preliminary review of votes cast, over 76% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene July 9, 2021 at 8:30 AM Pacific Standard Time to provide time to reach quorum.
-
Medexus Schedules Fiscal Year 2021 Conference Call
6/11/2021
Medexus Pharmaceuticals Inc. today announced that it plans to host a conference call at 8:00 AM Eastern Time on Thursday, June 17, 2021 to discuss the Company’s financial results for the fiscal year-ended March 31, 2021.
-
SCYNEXIS to Present at the BIO Digital International Convention 2021
6/11/2021
SCYNEXIS, Inc. today announced that Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, will present at the BIO Digital International Convention to be held virtually from June 10 – 11 and 14 – 18, 2021.
-
Pharvaris Announces Annual Meeting of Shareholders
6/11/2021
Pharvaris today announced the annual general meeting of shareholders will take place on Tuesday, June 29, 2021 at 1:00 p.m. CEST (7:00 a.m. EDT).
-
BeyondSpring to Host First Quarter Financial Results and Corporate Update Conference Call on June 16, 2021
6/11/2021
BeyondSpring Inc. today announced that management will host a conference call to report its financial results for the first quarter ended March 31, 2021 and provide an update on recent corporate events on June 16, 2021 at 8:30 AM Eastern Time.
-
Bright Minds Biosciences to Present at the H.C. Wainwright Virtual Conference Psychedelics in Psychiatry and Beyond
6/11/2021
Bright Minds Biosciences today announced that Ian McDonald, Chief Executive Officer, and Dr. Gideon Shapiro Ph.D, Vice President of Discovery, will be presenting at the H.C. Wainwright Virtual Conference.
-
Keros Therapeutics Presents Preclinical Data from ALK2 and KER-050 Hematology Programs at the European Hematology Association EHA2021 Virtual Congress
6/11/2021
Keros Therapeutics today presented data from the ALK2 and KER-050 hematology programs at the European Hematology Association EHA2021 Virtual Congress held from June 9 through June 17, 2021.
-
Imago BioSciences’ Bomedemstat Demonstrates Continued Encouraging Clinical Activity in Phase 2 Data for Treatment of Essential Thrombocythemia and Myelofibrosis at EHA 2021 Virtual Congress
6/11/2021
Imago BioSciences, Inc . today provided updates on two Phase 2 clinical trials of bomedemstat.
-
Aptose Presents Highlights from EHA During Corporate Update Event
6/11/2021
Aptose Biosciences Inc. is releasing highlights from a corporate update event being held today, Friday, June 11, 2021, at 8:00 a.m. ET.
-
Scholar Rock Presents TOPAZ Phase 2 Data Showing the Transformative Potential of Apitegromab in Patients with Type 2 and 3 Spinal Muscular Atrophy (SMA) at the 2021 Virtual SMA Research & Clinical Care Meeting
6/11/2021
Scholar Rock today announced an oral presentation of TOPAZ Phase 2 trial results by the lead principal investigator, Thomas Crawford, M.D. of Johns Hopkins Medicine, at the Cure SMA Annual SMA Conference.
-
Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA
6/11/2021
Eli Lilly and Company (NYSE: LLY) will host a webcast on Thursday, July 1, 2021 to discuss the company's diabetes portfolio and its presentations at the American Diabetes Association's Virtual 81st Scientific Sessions.
-
Vicarious Surgical to Present at the Cowen 6th Annual FutureHealth Conference on June 17th
6/11/2021
Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve cost, efficiency, and outcomes of surgical procedures, today announced that Adam Sachs, the Chief Executive Officer of Vicarious Surgical, will participate in the Cowen 6th Annual FutureHealth Conference,
-
Abbott Declares 390th Consecutive Quarterly Dividend
6/11/2021
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 45 cents per share.
-
FDA Takes Steps to Increase Availability of COVID-19 Vaccine
6/11/2021
Following careful review and deliberation, the U.S. Food and Drug Administration is taking important steps that will allow a critically needed supply of the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available.
-
Ampio Pharmaceuticals to Participate in the Alliance Global Partners' Virtual Summer Healthcare Symposium
6/11/2021
Ampio Pharmaceuticals (NYSE American: AMPE), today announced that management will participate in a series of one-on-one meetings with institutional investors throughout the day at the Alliance Global Partners' Virtual Summer Healthcare Symposium
-
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis ConcentratesProvides for minimum of approximately $11.4M in purchases over 3-year Period
6/11/2021
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it extended its distribution agreement with its long-term distribution partner, Nipro Medical Corporation (NMC), for a period of three years through May 2024.
-
Perimeter Medical Imaging AI to Participate in Panel Discussion “Innovations in Breast Cancer Detection, Surgery and Treatment” at the Lytham Partners Summer 2021 Investor Conference
6/11/2021
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF)(FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that the Company's Chief Executive Officer, Jeremy Sobotta, will participate in a panel at the Lytham Partners Summer 2021 Investor Conference
-
Bioresorbable Medical Material Market Size to Reach USD 2,193.01 Million in 2028, Says Reports and Data
6/11/2021
Increasing use of bioresorbable polymers in medical sector, rising number of orthopedic surgeries performed across the globe, and advancements in orthopedic bioresorbable implants are some key factors driving market growth.
-
Aspiration and Biopsy Needles Market | Increased Adoption of Industrial Automation Fuel Market Growth
6/11/2021
The needles that are used during aspiration and biopsy procedure have been gaining traction in the recent years. The market is competitive with the presence of many market players; each of them jostling with each other to expand the presence in the global aspiration and biopsy needles market.
-
Radiation Dermatitis Treatment Market Surging at 5% CAGR; Rising Prevalence of Skin Cancer Drives Growth: Fact.MR Study
6/11/2021
Fact MR: The global radiation dermatitis treatment market will surpass US$ 700 million by end of 2031.